<DOC>
	<DOCNO>NCT02326662</DOCNO>
	<brief_summary>This research investigate use autologous neural stem cell patient complete traumatic spinal cord injury .</brief_summary>
	<brief_title>Neural Stem Cell Transplantation Traumatic Spinal Cord Injury</brief_title>
	<detailed_description>The aim study evaluate Mesenchymal Stem Cells [ MSC ] -derived autologous neural stem cell transplantation safe potentially beneficial treatment patient traumatic spinal cord injury .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<criteria>Age 18 50 year old Traumatic spinal cord injury neck , thoracic lumbar level Classification ASIA A B significant improvement physical therapy/rehabilitation A score less 200 324point ASIA scale Injury duration 1 month 5 year An advanced , severe , unstable disease type may interfere primary secondary variable evaluation , include medical condition could expect progress , recur , change extent may bias assessment clinical mental status patient significant degree put patient special risk ( e.g. , severe liver kidney disease , malignancies/cancer ) Immune system disorder dysfunction Any major/serious infection 2 month prior inclusion A disability may prevent patient complete study requirement ( e.g. , blindness , deafness , severe language difficulty ) A current diagnosis active , uncontrolled peptic ulceration within last three month A current diagnosis acute , severe , unstable asthmatic condition [ e.g. , severe chronic obstructive pulmonary disease ( COPD ) ] Participated investigational trial within 4 week initial screen within 7 week study entry History regular alcohol intake drug abuse previous 3 month able sustain alcohol intake trial Cardiovascular A current diagnosis severe unstable cardiovascular disease A current diagnosis sicksinus syndrome conduction deficit ( e.g. , sinoatrial block , second third degree atrioventricular block ) A current diagnosis uncontrolled atrial fibrillation ( &gt; 100 bpm ) A current diagnosis moderate severe heart failure [ New York Heart Association ( NYHA ) , Class III ] A myocardial infarction ( MI ) know occur within last 3 month A current diagnosis severe unstable angina Vital sign ( supine ) outside follow range Systolic blood pressure 90 160 mmHg Diastolic blood pressure 55 95 mmHg Radial pulse 50 100 bpm CNS relate A recent history one year currently diagnose cerebrovascular disease ( e.g. , stroke transient ischemic attack , aneurysm ) A current diagnosis primary neurodegenerative disorder [ e.g. , Huntington 's disease , Parkinson 's disease etc . ] A current diagnosis active , uncontrolled seizure disorder Psychiatric A current DSMIV diagnosis major depression Any DSMIV Axis 1 diagnosis may interfere response patient study medication , include primary degenerative dementia , schizophrenia , bipolar disorder Laboratory abnormalities Clinically significant abnormality routine laboratory examination ( hematology , electrolytes , biochemistry , liver kidney function test , urinanalysis ) Concomitant therapy Previous stem cell treatment Ingested follow substance An investigational drug past 6 month A drug treatment know cause effect central nervous system [ CNS ] past four week A drug treatment know cause major organ system toxicity past four week Anticholinergic drug baseline Medication Parkinson 's disease baseline ( e.g. , selegiline , levodopa , amantadine , dopamine agonist , COMT inhibitor )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>spinal cord injury</keyword>
	<keyword>neural stem cell</keyword>
	<keyword>paraplegia</keyword>
	<keyword>transplantation</keyword>
</DOC>